Reduces Fibrosis and Scar Tissue Formation Fibrosis, or excessive scar tissue formation, can impair tissue flexibility and function
In the case of Wegovy, overweight or obese patients with preexisting cardiovascular disease who are prescribed the drug to prevent the risk of heart attacks or strokes may get Medicare coverage
The combination is now advancing into Phase 3 trials , expected to complete by 20262027
This can improve comfort and consistency when done correctly
Based on similar medications, retatrutide probably won't be recommended for: People with a personal or family history of medullary thyroid cancer Those with multiple endocrine neoplasia syndrome type 2 Anyone with a history of pancreatitis Pregnant or breastfeeding women Children and adolescents (under 18) People with severe kidney or liver disease Now, what about people without diabetes who want to lose weight
The result may be an increased appetite and tendency to regain weight